1 |
J. M. M. Walboomers et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology 189(1), 12-19. DOI : 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
DOI
|
2 |
M. E. McLaughlin-Drubin & K. Munger. (2008). Viruses associated with human cancer. Biochimica et Biophysica Acta 1782(3), 127-150. DOI : 10.1016/j.bbadis.2007.12.005
DOI
|
3 |
B. G. Kim. (2015). Update of human papillomavirus vaccination. Journal of the Korean Medical Association 58(4), 313-318. DOI : 10.5124/jkma.2015.58.4.313
DOI
|
4 |
A. Asiaf et al. (2014). Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection. European Journal of Cancer Prevention 23(3), 206-224. DOI : 10.1097/CEJ.0b013e328364f273
DOI
|
5 |
R. Reid et al. (1982). Genital warts and cervical cancer. I. Evidence of an association between subclinical papillomavirus infection and cervical malignancy. Cancer 50(2), 377-387. DOI : 10.1002/1097-0142(19820715)50:2<377::AID-CNCR2820500236>3.0.CO;2-A
DOI
|
6 |
Future II Study Group. (2007). Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. New England Journal of Medicine 356(19), 1915-1927. DOI : 10.1056/NEJMoa061741
DOI
|
7 |
S. H. Kim et al. (2009). Factors related to human papilloma virus infection rate in women. Korean Journal of Family Medicine 30(12), 972-978. DOI : 10.4082/kjfm.2009.30.12.972
DOI
|
8 |
H. Sung et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians 71(3), 209-249. DOI : 10.3322/caac.21660
DOI
|
9 |
A. M. Park & S. B. Koh. (2008). Prevalence and Distribution of Single and Multiple HPV Infections in Cervical Cancer and Precancerous Lesion From Daegu and Gyeongbuk Province. Korean Journal of Obstetrics and Gynecology 51(10), 1128-1136.
|
10 |
H. R. Shin et al. (2004). Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. Journal of Infectious Diseases 190(3), 468-476. DOI : 10.1086/421279
DOI
|
11 |
S. K. Kjaer et al. (2010). Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. Journal of the National Cancer Institute 102.19, 1478-1488. DOI : 10.1093/jnci/djq356
DOI
|
12 |
R. Sankaranarayanan et al. (2009). HPV screening for cervical cancer in rural India. New England Journal of Medicine, 360(14), 1385-1394. DOI : 10.1056/NEJMoa0808516
DOI
|
13 |
E. Lazcano-Ponce et al. (2001). Epidemiology of HPV infection among Mexican women with normal cervical cytology. International Journal of Cancer 91(3), 412-420. DOI : 10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M
DOI
|
14 |
R. Herrero et al. (2000). Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. Journal of the National Cancer Institute 92(6), 464-474. DOI : 10.1093/jnci/92.6.464
DOI
|
15 |
K. A. et al. (2016). The impact of high-risk HPV genotypes other than HPV 16/18 on the natural course of abnormal cervical cytology: a Korean HPV cohort study. Cancer Research and Treatment 48(4), 1313-1320. DOI : 10.4143/crt.2016.013
DOI
|
16 |
N. Munoz et al. (2006). Chapter 1: HPV in the etiology of human cancer. Vaccine 24 (Suppl 3), S1-S10. DOI : 10.1016/j.vaccine.2006.05.115
DOI
|
17 |
S. J. Goldie et al. (2007). Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine 25(33), 6257-6270. DOI : 10.1016/j.vaccine.2007.05.058
DOI
|
18 |
World Health Organization. (2017). Human papillomavirus vaccines: WHO position paper, May 2017 Wkly Epidemiol Rec. 2217;92(19), 241-68.
|
19 |
K. N. Lee et al. (2017). Attitudes regarding HPV vaccinations of children among mothers with adolescent daughters in Korea. Journal of Korean Medical Science 32(1), 130-134. DOI : 10.3346/jkms.2017.32.1.130
DOI
|
20 |
W. D. Joo et al. (2004). Prevalence of human papillomavirus infection in Korean women: risks of abnormal pap smear and cervical neoplasia. Korean Journal of Gynecologic Oncology and Colposcopy 15.4, 309-316. DOI : 10.3802/kjgoc.2004.15.4.309
DOI
|
21 |
K. K. Vesco et al. (2011). Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the US Preventive Services Task Force. Annals of Internal Medicine 155(10), 698-705, W216. DOI : 10.7326/0003-4819-155-10-201111150-00377
DOI
|
22 |
G Ronco et al. (2014). Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. The Lancet 383(9916), 524-532. DOI : 10.1016/S0140-6736(13)62218-7
DOI
|
23 |
H. R. Shin et al. (2003). Prevalence of human papillomavirus infection in women in Busan, South Korea. International Journal of Cancer 103(3), 413-421. DOI : 10.1002/ijc.10825
DOI
|
24 |
AT. Lorincz et al. (1987). Oncogenic association of specific human papillomavirus types with cervical neoplasia. Journal of the National Cancer Institute 79(4), 671-677. DOI : 10.1093/jnci/79.4.671
DOI
|